iShares U.S. Pharmaceuticals ETF

Frequently Asked Questions About IHE

What does IHE invest in?

The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.

What is the expense ratio of IHE?

iShares U.S. Pharmaceuticals ETF (IHE) charges an expense ratio of 0.37%. This is the annual fee deducted from fund assets to cover management and operations.

How big is IHE?

iShares U.S. Pharmaceuticals ETF (IHE) manages $1.67B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is IHE actively managed or an index fund?

IHE is a passive index fund — it tracks a published benchmark by holding the constituents in their published weights. Index funds typically charge low expense ratios (IHE's is 0.37%) because there's no security selection cost.

When was IHE launched?

iShares U.S. Pharmaceuticals ETF (IHE) launched in April 2006 and is managed by IShares.

How has IHE performed?

IHE's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.